Clinical Trials Browser

INDUSTRY × Neurofibromatosis 1 × 30 days × Clear all

Neurofibromatosis 1

NCT03962543 2026-04-08

ReNeu

Phase 2 Active not recruiting

114 enrolled 25 charts 3 FDA

CNS

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses, Neurofibroma, Plexiform

NCT03975829 2026-04-02

Pediatric Long-Term Follow-up and Rollover Study

Phase 4 Active not recruiting

163 enrolled

CNSMyeloid

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT06360406 2026-03-31

Real-World Treatment Study of Koselugo (Selumetinib)

Recruiting

200 enrolled

CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

NCT04924608 2026-03-23

KOMET

Phase 3 Active not recruiting

145 enrolled 17 charts 3 FDA

CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

NCT06541847 2026-03-20

INSPIRE-NF1

Phase 2 Recruiting

25 enrolled

CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Clinical Trials

PRECIOUS Egypt

ReNeu

Pediatric Long-Term Follow-up and Rollover Study

Real-World Treatment Study of Koselugo (Selumetinib)

KOMET

INSPIRE-NF1